Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients

Mutations in the cardiac ryanodine receptor (RYR2) are the leading cause for catecholaminergic polymorphic ventricular tachycardia (CPVT). In this study, we evaluated antiarrhythmic efficacy of carvedilol and flecainide in CPVT patient-specific induced pluripotent stem cell-derived cardiomyocytes (i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pölönen, R. P., Penttinen, K., Swan, H., Aalto-Setälä, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924967/
https://www.ncbi.nlm.nih.gov/pubmed/29760739
http://dx.doi.org/10.1155/2018/9109503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924967/
https://www.ncbi.nlm.nih.gov/pubmed/29760739
http://dx.doi.org/10.1155/2018/9109503

Ejemplares similares